Navigation Links
diaDexus, Inc. Reports 2011 Fourth Quarter and Year-End Financial Results
Date:3/16/2012

its guidance for 2012 total revenues at $20 million to $21 million, projecting year-over-year growth of approximately 26% compared to 2011.  The company believes it will use approximately $6 million in operations. Future financing needs will depend on the company's ability to increase the rate of adoption for the company's products by physicians, progress in achieving additional positive coverage decisions from insurers for the PLAC® Test for Lp-PLA(2), and commercialization needs.

"diaDexus had an outstanding fiscal 2011, the strongest fourth quarter in the history of the company, and grew revenues to a record of $16.4 million," said Brian Ward, Ph.D., diaDexus' Chief Executive Officer. "We are gaining strong momentum with acceptance of the PLAC Lp-PLA(2) Mass testing as an essential biomarker that aids physicians by indicating the risk of cardiovascular heart disease and stroke in the United States. With the launch of diaDexus' new PLAC® Test for Lp-PLA(2) Activity in Europe in the first quarter of 2012, we are now positioned for further long-term sales momentum.  The recent hire of Jean Viret as our Chief Financial Officer completes our executive management team, and allows us to maintain our sales momentum and deliver increased value to our shareholders."

Webcast

diaDexus will host a webcast on Thursday, March 15 at 1:15 PM PDT (4:15 PM EDT) to discuss the 2011 fourth quarter and year-end financial results. The webcast may be accessed via the company's website at www.diadexus.com/webcast.

About diaDexus, Inc.

diaDexus, Inc., based in South San Francisco, California, is focused on the development and commercialization of proprietary in vitro diagnostic products addressing unmet needs in cardiovascular disease. The company's PLAC® Test for Lp-PLA(2) is the only blood test cleared by the FDA to aid in assessing risk for both coronary heart disease and i
'/>"/>

SOURCE diaDexus, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. diaDexus, Inc. Adds Two New Directors; Corporate Overview & 3Q Results Webcast Set for November 16, 2010
2. diaDexus, Inc. Reports 2010 Third Quarter Financial Results
3. diaDexus, Inc. Reports 2011 First Quarter Financial Results
4. diaDexus, Inc. Reports 38% Year-Over-Year Revenue Growth for 2011 Third Quarter
5. diaDexus, Inc. to Host Webcast March 15, 2012 on 2011 Fourth Quarter and Year-End Financial Results
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Spherix Reports Second Quarter Earnings
8. Tapestry Reports Second Quarter 2007 Results
9. Callisto Reports on Second-Quarter 2007 Milestones
10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)...   Plexus Information Systems, Inc. (Plexus ... Systems (AIMS), announced a partnership with NextGen ... subsidiary of Quality Systems, Inc. and a leading ... Logo - http://photos.prnewswire.com/prnh/20140930/149406 ... This partnership extends the NextGen Healthcare product portfolio ...
(Date:10/1/2014)... NOTTINGHAM, England , Oct. 1, 2014  Columbia ... that its subsidiary, Molecular Profiles Ltd., is set to ... annual CPhI/ICSE Worldwide event in Paris ... the rapid development of both standard and complex drug ... which incorporates the company,s existing formulation and analytical development ...
(Date:10/1/2014)... and NEW YORK , October 1, ... Research Organization (CRO) and service provider for the medical industries, announced ... of offices in New York City . genae ... City is strategically centered in one of the highest ... Coast", said Philippe Kassab , President at genae Americas. "The ...
Breaking Medicine Technology:Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 2Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 3Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 2Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 3genae Opens Offices in New York City 2
... a Deadly ... but Vaccine-Preventable Disease, WASHINGTON, Oct. 16 Parents ... its national,educational campaign "Silence the Sounds of Pertussis" with actress ... about the dangers of pertussis and alerts,parents to the need ...
... West Pharmaceutical,Services, Inc. (NYSE: WST ) today ... Thomas W. Hofmann. Mr. Hofmann, 56, is Senior Vice,President ... SUN ), a,position he has held since 1998. He ... largest independent,refiner-marketers of petroleum products in the United States. ...
Cached Medicine Technology:Actress and New Mom Keri Russell Joins PKIDs to launch 'Silence the Sounds of Pertussis' Campaign 2Actress and New Mom Keri Russell Joins PKIDs to launch 'Silence the Sounds of Pertussis' Campaign 3West Pharmaceutical Services, Inc. Appoints New Director 2
(Date:10/1/2014)... Phoseon Technology, the pioneer in developing ... the business worldwide. This rapid growth includes increased hiring ... manufacturing efforts. The company has experienced average annual growth ... expects this growth to continue in the future as ... adoption. , “We are very pleased that ...
(Date:10/1/2014)... 01, 2014 Farmington Company today ... redefined mission and visual identity helping brokers, consultants ... with them to create greater benefit communication synergies. ... focuses on empowering customers to better leverage Farmington ... crown jewel of the rebrand is the refreshed ...
(Date:10/1/2014)... N.C. A new genetic finding from Duke Medicine ... anxiety and depression might also be hard-wired to gain ... and heart disease. , An estimated 13 percent of ... genetic susceptibility, and knowing this could help them reduce ... diet, exercise and stress management. , "Genetic susceptibility, psychosocial ...
(Date:10/1/2014)... October 01, 2014 Between 23 million ... the U.S., according to figures from the National Institutes ... Association (AARDA), and many of them have something else ... having undiagnosed celiac disease. Gluten Free Therapeutics, makers ... of undiagnosed celiac disease by publishing a series of ...
(Date:10/1/2014)... Jersey City, NJ (PRWEB) October 01, 2014 ... sticking with their intentions to lose weight and their dieting ... in unhealthy, fatty foods. Including hormone diet treatments ... not only allows patients to see fast and effective weight ... diet and begin forming healthy habits to maintain their weight ...
Breaking Medicine News(10 mins):Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4
... ... Saudi Arabia, SOMERSET, N.J., ... subsidiary AWT International, Inc.,has opened new sales offices in Saudi Arabia. ... U.S. healthcare industry. The Company has hired 2 highly experienced ...
... one source of frustration, study finds , TUESDAY, Oct. 9 ... U.S. Hispanics, ability to get good health care, a new ... have difficulty navigating the health care system, say researchers reporting ... , In this study, a team led by Robert Weech-Maldonado, ...
... Oct. 8, 2007 Two UT Southwestern Medical Center ... neuroscientist have been elected to the Institute of ... Sciences. , Dr. Luis Parada, professor and chairman ... chairman of neuroscience, were among 65 new national members ...
... financial and clinical ... -- Announces name change from ... Today, UPCARE Technology, Inc.,unveiled its new UPCARE(R) E2E lab performance ... of its parent company, Marquette,General Health System (MGHS). The company ...
... Oct. 9 Many Americans are obsessed with,staying in ... being,mentally fit. More Americans are becoming aware of the ... knowledge, intelligence, and quick,wits are rewarded. Being mentally fit ... train your brain have been lacking,until recently. A ...
... Award-winning Internet job board establishes new social and professional ... and health care community, LAKE WORTH, Fla., Oct. 9 ... care field, your job is extremely demanding, perhaps,even all-consuming. Finding ... tough, as is catching up on the latest industry news ...
Cached Medicine News:Health News:AWT, Inc. Continues Rapid Expansion in Middle East 2Health News:AWT, Inc. Continues Rapid Expansion in Middle East 3Health News:Many U.S. Hispanics Struggle With Health Care System 2Health News:2 UT Southwestern researchers elected to National Academy of Sciences' Institute of Medicine 2Health News:2 UT Southwestern researchers elected to National Academy of Sciences' Institute of Medicine 3Health News:UPCARE Technology to Share the Secrets of its Parent's Success in Lab Outreach 2Health News:UPCARE Technology to Share the Secrets of its Parent's Success in Lab Outreach 3Health News:UPCARE Technology to Share the Secrets of its Parent's Success in Lab Outreach 4Health News:Online Game from BrainGrade Can Raise Brain I.Q. 2Health News:Absolutely Health Care Launches MedicalMingle.com 2
... level. Incredibly quiet, yet very powerful. Attachment ... at one time eliminates the need to ... canister set-up is for Abbott 2000ml system ... and CE marks. Includes a wireless foot-switch. ...
Richardson Retractors...
Our most popular saline breast implant style for over 20 years. A full, rounded look that adds greater dimension to the breast....
Inquire...
Medicine Products: